Join
Live feed
·
PRReleasevia Quantisnow
Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists

ByQuantisnow·Wall Street's wire, on your screen.
VNDA· Vanda Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VNDA (Vanda Pharmaceuticals Inc.) and more on Quantisnow.